Mechanisms of Resistance to Antibody-Drug Conjugates

The treatment of cancer patients has dramatically changed over the past decades with the advent of monoclonal antibodies, immune-checkpoint inhibitors, bispecific antibodies, and innovative T-cell therapy. Antibody-drug conjugates (ADCs) have also revolutionized the treatment of cancer. Several ADCs...

Descripción completa

Detalles Bibliográficos
Autores principales: Khoury, Rita, Saleh, Khalil, Khalife, Nadine, Saleh, Mohamad, Chahine, Claude, Ibrahim, Rebecca, Lecesne, Axel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10253543/
https://www.ncbi.nlm.nih.gov/pubmed/37298631
http://dx.doi.org/10.3390/ijms24119674

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10253543/
https://www.ncbi.nlm.nih.gov/pubmed/37298631
http://dx.doi.org/10.3390/ijms24119674

Ejemplares similares